{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06099782",
            "orgStudyIdInfo": {
                "id": "3475A-F11"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-506017-22",
                    "type": "REGISTRY",
                    "domain": "EU CT"
                },
                {
                    "id": "U1111-1293-0814",
                    "type": "OTHER",
                    "domain": "UTN"
                },
                {
                    "id": "MK-3475A-F11",
                    "type": "OTHER",
                    "domain": "Merck"
                },
                {
                    "id": "jRCT2051230147",
                    "type": "REGISTRY",
                    "domain": "Japan Registry of Clinical Trials (jRCT)"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)",
            "officialTitle": "A Phase 2 Study to Evaluate Patient Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab Formulation in Participants With Multiple Tumor Types (MK-3475A-F11)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-participant-reported-preference-for-subcutaneous-pembrolizumab-coformulated-with-hyaluronidase-mk-over-intravenous-pembrolizumab-mk-formulation-in-multiple-tumor-types-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-11-16",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-19",
            "studyFirstSubmitQcDate": "2023-10-19",
            "studyFirstPostDateStruct": {
                "date": "2023-10-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate participant preference for coformulated hyaluronidase/pembrolizumab (MK-3475A) administered subcutaneously (SC) over pembrolizumab (MK-3475) administered intravenously (IV) in participants with multiple tumor types. There will be no hypothesis testing in this study."
        },
        "conditionsModule": {
            "conditions": [
                "Non-Small Cell Lung Cancer",
                "Renal Cell Carcinoma",
                "Melanoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 144,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm A: MK-3475A SC \u2192Pembrolizumab IV",
                    "type": "EXPERIMENTAL",
                    "description": "In the treatment crossover period, participants will receive MK-3475A SC followed by pembrolizumab IV. After completion of the treatment crossover period, participants will enter the treatment continuation period, where they will receive their preferred intervention for up to \\~1 year for renal cell carcinoma (RCC) and melanoma and for up to \\~2 years for non-small cell lung cancer (NSCLC).",
                    "interventionNames": [
                        "Biological: Pembrolizumab co-formulated with hyaluronidase",
                        "Biological: Pembrolizumab"
                    ]
                },
                {
                    "label": "Arm B: Pembrolizumab IV\u2192MK-3475A SC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "In the treatment crossover period, participants will receive pembrolizumab IV followed by MK-3475A SC. After completion of the treatment crossover period, participants will enter the treatment continuation period, where they will receive their preferred intervention for up to \\~1 year for RCC and melanoma and for up to \\~2 years for NSCLC.",
                    "interventionNames": [
                        "Biological: Pembrolizumab co-formulated with hyaluronidase",
                        "Biological: Pembrolizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Pembrolizumab co-formulated with hyaluronidase",
                    "description": "Fixed dose coformulated product of hyaluronidase/pembrolizumab adminstered via SC injection.",
                    "armGroupLabels": [
                        "Arm A: MK-3475A SC \u2192Pembrolizumab IV",
                        "Arm B: Pembrolizumab IV\u2192MK-3475A SC"
                    ],
                    "otherNames": [
                        "MK-3475A"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Pembrolizumab",
                    "description": "Administered via IV infusion",
                    "armGroupLabels": [
                        "Arm A: MK-3475A SC \u2192Pembrolizumab IV",
                        "Arm B: Pembrolizumab IV\u2192MK-3475A SC"
                    ],
                    "otherNames": [
                        "MK-3475, KEYTRUDA\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Participants Who Prefer MK-3475A Subcutaneous (SC) on Patient Preference Questionnaire (PPQ) Question 1",
                    "description": "The PPQ is an instrument that has been developed from participant interviews and includes questions to evaluate directly from participants their preference regarding mode of administration, as well as the strength of the preference, and the reason for the preference. Question 1 in PPQ evaluates participants' preferred method of administration with response options of IV, SC or no preference. The percentage of participants who prefer SC will be reported.",
                    "timeFrame": "~Day 106"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of Responses From Participants to the Two Main Reasons for Their Preferred Method of Administration as Assessed on PPQ Question 3",
                    "description": "The PPQ is an instrument that has been developed from patient interviews and includes questions to evaluate directly from participants their preference regarding mode of administration, as well as the strength of the preference, and the reason for the preference. Question 3 in PPQ evaluates two main reasons for participants' preference for one of the administration methods with response options of feels less emotionally distressing, requires less time in the clinic, lower level injection-site pain, among others. The percentage of responses from participants to the two main reasons for their preferred method of administration, as assessed on PPQ Question 3 will be reported.",
                    "timeFrame": "~Day 106"
                },
                {
                    "measure": "Percentage of Participants by Their Level of Satisfaction With the SC Method of Administration as assessed on Therapy Administration Satisfaction Questionnaire - Subcutaneous (TASQ-SC) Question 1",
                    "description": "The TASQ SC is a 12-item questionnaire that asks questions regarding different aspects of participants' satisfaction with SC administration, experiences related to administration, convenience, time. Question 1 in TASQ SC evaluates participants' satisfaction or dissatisfaction with SC administration. The percentage of participants by their level of satisfaction with the SC method of administration as assessed on TASQ-SC Question 1 will be reported.",
                    "timeFrame": "Up to ~Day 106"
                },
                {
                    "measure": "Percentage of Participants by Their Level of Satisfaction With the IV Method of Administration as assessed on Therapy Administration Satisfaction Questionnaire -Intravenous (TASQ-IV) Question 1",
                    "description": "The TASQ IV is a 12-item questionnaire that asks questions regarding different aspects of participants' satisfaction with IV administration, experiences related to administration, convenience, time. Question 1 in TASQ IV evaluates participants' satisfaction or dissatisfaction with IV administration. The percentage of participants by their level of satisfaction with the IV method of administration as assessed on TASQ-IV Question 1 will be reported.",
                    "timeFrame": "Up to ~Day 106"
                },
                {
                    "measure": "Percentage of Participants Who Choose MK-3475A SC for the Study Treatment Continuation Period",
                    "description": "The percentage of participants who choose SC treatment for the continuation period in the study will be reported.",
                    "timeFrame": "~Day 106"
                },
                {
                    "measure": "Number of Participants Who Experience an Adverse Event (AE)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to ~27 months"
                },
                {
                    "measure": "Number of participants who discontinue study drug due to an AE",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to ~24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Has a histologically- or cytologically-confirmed early stage or advanced/ metastatic solid tumor by pathology report and meet the following conditions based on tumor type:\n\n  * Surgically resected Stage IIB and IIC (pathological or clinical), or III cutaneous melanoma per American Joint Committee on Cancer (AJCC) eighth edition.\n  * Surgically resected renal cell carcinoma (RCC) with intermediate-high or high risk of recurrence as defined by the Fuhrman grading status.\n  * Stage IV non-small cell lung cancer (NSCLC) per AJCC eight edition, with an anti-programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) \u226550% determined using the Dako PD-L1 immunohistochemistry (IHC) 22C3 pharmDx diagnostic kit, and confirmation that epidermal growth factor receptor (EGFR-), anaplastic lymphoma kinase (ALK-), or c-ros oncogene 1 (ROS1)- directed therapy is not indicated as primary therapy.\n* Has a life expectancy of at least 3 months.\n* Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART).\n* Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load before randomization.\n* Participants with history of hepatitis C virus (HCV) infection are eligible if have completed curative antiviral therapy at least 4 weeks before randomization and HCV viral load is undetectable at screening.\n* Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 assessed within 3 days before the start of study intervention.\n\nExclusion Criteria:\n\n* Non-small cell lung cancer (NSCLC) participants with a diagnosis of small cell lung cancer or, for mixed tumors, presence of small cell elements.\n* Melanoma participants with ocular, mucosal, or conjunctival melanoma.\n* Renal Cell Carcinoma (RCC) participants who have had major surgery, other than nephrectomy, within 12 weeks before randomization.\n* Has received prior radiotherapy for RCC.\n* RCC participants who have residual thrombus post nephrectomy in the vena renalis or vena cava.\n* Has received prior therapy with an anti-programmed cell death 1 protein (PD-1), PD-L1, or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor (eg, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), OX-40, CD137).\n* Has received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization.\n* Has received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines is allowed.\n* Received prior radiotherapy within 2 weeks of start of study intervention, or has radiation-related toxicities, requiring corticosteroids.\n* Received prior systemic anticancer therapy for their metastatic NSCLC. Note: Prior treatment with neoadjuvant or adjuvant therapy for nonmetastatic NSCLC is allowed as long as therapy was completed at least 12 months before diagnosis of metastatic NSCLC.\n* Received radiation therapy to the lung that is \\>30 Gray within 6 months of start of study intervention.\n* Has received an investigational agent or has used an investigational device within 4 weeks prior to study intervention administration.\n* Has diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication.\n* Has known additional malignancy that is progressing or has required active treatment within the past 3 years.\n* Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.\n* Has active autoimmune disease that has required systemic treatment in the past 2 years.\n* Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease.\n* Has active infection requiring systemic therapy.\n* HIV-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease.\n* Has history of allogeneic tissue/solid organ transplant corticosteroids.\n* Has severe hypersensitivity (\u2265Grade 3) to pembrolizumab and/or any of its excipients.\n* Has not adequately recovered from major surgery or have ongoing surgical complications.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Alaska Oncology and Hematology ( Site 0121)",
                    "status": "RECRUITING",
                    "city": "Anchorage",
                    "state": "Alaska",
                    "zip": "99508",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "907-257-9851"
                        }
                    ],
                    "geoPoint": {
                        "lat": 61.21806,
                        "lon": -149.90028
                    }
                },
                {
                    "facility": "Highlands Oncology Group-Research Department ( Site 0133)",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "479-587-1700"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "Marin Cancer Care ( Site 0148)",
                    "status": "RECRUITING",
                    "city": "Greenbrae",
                    "state": "California",
                    "zip": "94904",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "415-925-5000"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.94854,
                        "lon": -122.5247
                    }
                },
                {
                    "facility": "Mid Florida Hematology and Oncology Center ( Site 0113)",
                    "status": "RECRUITING",
                    "city": "Orange City",
                    "state": "Florida",
                    "zip": "32763",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "407-353-1915"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.94888,
                        "lon": -81.29867
                    }
                },
                {
                    "facility": "Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0112)",
                    "status": "RECRUITING",
                    "city": "Marietta",
                    "state": "Georgia",
                    "zip": "30060",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "770-281-5100"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.9526,
                        "lon": -84.54993
                    }
                },
                {
                    "facility": "Kadlec Clinic Hematology and Oncology ( Site 0103)",
                    "status": "RECRUITING",
                    "city": "Kennewick",
                    "state": "Washington",
                    "zip": "99336",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "509-942-2540"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.21125,
                        "lon": -119.13723
                    }
                },
                {
                    "facility": "Instituto de Investigaciones Cl\u00ednicas Mar del Plata ( Site 0300)",
                    "status": "RECRUITING",
                    "city": "Mar del Plata",
                    "state": "Buenos Aires",
                    "zip": "B7600FZO",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+5492235937663"
                        }
                    ],
                    "geoPoint": {
                        "lat": -38.00228,
                        "lon": -57.55754
                    }
                },
                {
                    "facility": "Fundaci\u00f3n Respirar ( Site 0302)",
                    "status": "RECRUITING",
                    "city": "Buenos Aires",
                    "state": "Caba",
                    "zip": "C1426ABP",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+541151082017"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Instituto San Marcos ( Site 0305)",
                    "status": "RECRUITING",
                    "city": "San Juan",
                    "zip": "J5400EBB",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+54 9 264 5017141"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.5375,
                        "lon": -68.53639
                    }
                },
                {
                    "facility": "Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 1001)",
                    "status": "RECRUITING",
                    "city": "Port Macquarie",
                    "state": "New South Wales",
                    "zip": "2444",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61265814053"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.43084,
                        "lon": 152.90894
                    }
                },
                {
                    "facility": "Frankston Hospital-Oncology and Haematology ( Site 1007)",
                    "status": "RECRUITING",
                    "city": "Frankston",
                    "state": "Victoria",
                    "zip": "3199",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0417129607"
                        }
                    ],
                    "geoPoint": {
                        "lat": -38.14458,
                        "lon": 145.12291
                    }
                },
                {
                    "facility": "Centro Investigacion Cancer James Lind ( Site 0408)",
                    "status": "RECRUITING",
                    "city": "Temuco",
                    "state": "Araucania",
                    "zip": "4810469",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56994443272"
                        }
                    ],
                    "geoPoint": {
                        "lat": -38.73965,
                        "lon": -72.59842
                    }
                },
                {
                    "facility": "Cl\u00ednica Puerto Montt ( Site 0404)",
                    "status": "RECRUITING",
                    "city": "Puerto Montt",
                    "state": "Los Lagos",
                    "zip": "5500243",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56998634501"
                        }
                    ],
                    "geoPoint": {
                        "lat": -41.46691,
                        "lon": -72.94956
                    }
                },
                {
                    "facility": "FALP-UIDO ( Site 0401)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7500921",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56224457254"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Oncovida ( Site 0403)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7510032",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "5624205100"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0407)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "8330032",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56223546919"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Bradfordhill-Clinical Area ( Site 0402)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "8420383",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56998744662"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "ONCOCENTRO APYS-ACEREY ( Site 0400)",
                    "status": "RECRUITING",
                    "city": "Vi\u00f1a del Mar",
                    "state": "Valparaiso",
                    "zip": "2520598",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56992369820"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.02457,
                        "lon": -71.55183
                    }
                },
                {
                    "facility": "Centre Hospitalier Universitaire de Caen Normandie-DERMATOLOGY ( Site 0604)",
                    "status": "RECRUITING",
                    "city": "Caen",
                    "state": "Calvados",
                    "zip": "14000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33231065227"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.18585,
                        "lon": -0.35912
                    }
                },
                {
                    "facility": "Clinique Francois Chenieux ( Site 0603)",
                    "status": "RECRUITING",
                    "city": "Limoges",
                    "state": "Haute-Vienne",
                    "zip": "87039",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33555454800"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.83153,
                        "lon": 1.25781
                    }
                },
                {
                    "facility": "H\u00f4pital Bichat - Claude-Bernard ( Site 0605)",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "state": "Ile-de-France",
                    "zip": "75018",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0679854698"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "CENTRE LEON BERARD-onco dermatology ( Site 0600)",
                    "status": "RECRUITING",
                    "city": "Lyon Cedex08",
                    "state": "Rhone-Alpes",
                    "zip": "69373",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33478785996"
                        }
                    ]
                },
                {
                    "facility": "HIA Sainte Anne-Pneumology ( Site 0601)",
                    "status": "RECRUITING",
                    "city": "Toulon",
                    "state": "Var",
                    "zip": "83800 Cedex 9",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0033483162937"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.12442,
                        "lon": 5.92836
                    }
                },
                {
                    "facility": "Bell Land General Hospital ( Site 1101)",
                    "status": "RECRUITING",
                    "city": "Sakai",
                    "state": "Osaka",
                    "zip": "599-8247",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+81-72-234-2001"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.58333,
                        "lon": 135.46667
                    }
                },
                {
                    "facility": "Tokyo Women's Medical University ( Site 1100)",
                    "status": "RECRUITING",
                    "city": "Tokyo",
                    "zip": "162-8666",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+81-3-3353-8111"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.6895,
                        "lon": 139.69171
                    }
                },
                {
                    "facility": "Auckland City Hospital-Cancer & Blood Research ( Site 1051)",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "1023",
                    "country": "New Zealand",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "64212407080"
                        }
                    ],
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Bowen Hospital ( Site 1050)",
                    "status": "RECRUITING",
                    "city": "Wellington",
                    "zip": "6035",
                    "country": "New Zealand",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6443855999"
                        }
                    ],
                    "geoPoint": {
                        "lat": -41.28664,
                        "lon": 174.77557
                    }
                },
                {
                    "facility": "Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 0701)",
                    "status": "RECRUITING",
                    "city": "Bydgoszcz",
                    "state": "Kujawsko-pomorskie",
                    "zip": "85-796",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "48501446778"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.1235,
                        "lon": 18.00762
                    }
                },
                {
                    "facility": "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "state": "Mazowieckie",
                    "zip": "02-781",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "48225463066"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Szpital Wojew\u00f3dzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0702)",
                    "status": "RECRUITING",
                    "city": "Koszalin",
                    "state": "Zachodniopomorskie",
                    "zip": "75-581",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "48502204953"
                        }
                    ],
                    "geoPoint": {
                        "lat": 54.19438,
                        "lon": 16.17222
                    }
                },
                {
                    "facility": "Zachodniopomorskie Centrum Onkologii ( Site 0703)",
                    "status": "RECRUITING",
                    "city": "Szczecin",
                    "state": "Zachodniopomorskie",
                    "zip": "71-730",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "48914251502"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.42894,
                        "lon": 14.55302
                    }
                },
                {
                    "facility": "Cancer Care Langenhoven Drive Oncology Centre ( Site 0808)",
                    "status": "RECRUITING",
                    "city": "Port Elizabeth",
                    "state": "Eastern Cape",
                    "zip": "6045",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "27413630581"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.91799,
                        "lon": 25.57007
                    }
                },
                {
                    "facility": "Medical Oncology Centre of Rosebank ( Site 0805)",
                    "status": "RECRUITING",
                    "city": "Johannesburg",
                    "state": "Gauteng",
                    "zip": "2196",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0824445473"
                        }
                    ],
                    "geoPoint": {
                        "lat": -26.20227,
                        "lon": 28.04363
                    }
                },
                {
                    "facility": "Nosworthy Oncology ( Site 0807)",
                    "status": "RECRUITING",
                    "city": "Johannesburg",
                    "state": "Gauteng",
                    "zip": "2196",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+27114823593"
                        }
                    ],
                    "geoPoint": {
                        "lat": -26.20227,
                        "lon": 28.04363
                    }
                },
                {
                    "facility": "Steve Biko Academic Hospital-Medical Oncology ( Site 0804)",
                    "status": "RECRUITING",
                    "city": "Pretoria",
                    "state": "Gauteng",
                    "zip": "0001",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "27123541054"
                        }
                    ],
                    "geoPoint": {
                        "lat": -25.74486,
                        "lon": 28.18783
                    }
                },
                {
                    "facility": "LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 0800)",
                    "status": "RECRUITING",
                    "city": "Pretoria",
                    "state": "Gauteng",
                    "zip": "0181",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "27123466701"
                        }
                    ],
                    "geoPoint": {
                        "lat": -25.74486,
                        "lon": 28.18783
                    }
                },
                {
                    "facility": "Cape Town Oncology Trials ( Site 0802)",
                    "status": "RECRUITING",
                    "city": "Cape Town",
                    "state": "Western Cape",
                    "zip": "7570",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "27219443832"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.92584,
                        "lon": 18.42322
                    }
                },
                {
                    "facility": "CANCERCARE RONDEBOSCH ONCOLOGY-Cancercare Rondebosch Oncology ( Site 0806)",
                    "status": "RECRUITING",
                    "city": "Cape Town",
                    "state": "Western Cape",
                    "zip": "7700",
                    "country": "South Africa",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "27219443700"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.92584,
                        "lon": 18.42322
                    }
                },
                {
                    "facility": "Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 0903)",
                    "status": "RECRUITING",
                    "city": "Adana",
                    "zip": "01140",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905056166338"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.00167,
                        "lon": 35.32889
                    }
                },
                {
                    "facility": "Hacettepe Universite Hastaneleri-oncology hospital ( Site 0900)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06230",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+905334318506"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Ankara Bilkent \u015eehir Hastanesi-Medical Oncology ( Site 0901)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06800",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905052933234"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Ege Universitesi Hastanesi ( Site 0902)",
                    "status": "RECRUITING",
                    "city": "\u0130zmir",
                    "zip": "35100",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905332117153"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.41273,
                        "lon": 27.13838
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "https://www.merckclinicaltrials.com/"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=3475A-F11&&kw=3475A-F11"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002292",
                    "term": "Carcinoma, Renal Cell"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000007680",
                    "term": "Kidney Neoplasms"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5548",
                    "name": "Carcinoma, Renal Cell",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M10703",
                    "name": "Kidney Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4906",
                    "name": "Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1341",
                    "name": "Clear Cell Renal Cell Carcinoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}